Table 1.
Summary of blast hits to integrons found in this collection
Rows in bold indicate integrons with no 100% matches. The closest integron match is provided
|
Integron |
Accession no. |
Coverage; Identity |
Integron location |
Inc group (pMLST) |
Isolation date |
Species (ST)/ [STs from this collection] |
Host |
Host disease |
Host location |
|---|---|---|---|---|---|---|---|---|---|
|
a |
100 %; 100 % |
Plasmid |
I1 (CC-3) |
2013 |
E. coli (na)/[ST10] |
Chicken |
na |
Belgium |
|
|
100 %; 100 % |
Plasmid |
F (F-:A18:B-) |
2016 |
E. coli (ST617) |
Human |
na |
Germany |
||
|
b |
93 %; 100 % |
Chromosome |
– |
2016 |
P. aeruginosa (ST357)/[ST95] |
Human |
Sepsis |
India |
|
|
c |
100 %; 100 % |
Plasmid |
F (F2:A-:B1) |
2010 |
E. coli (ST58)/[ST58, ST117, ST141] |
Cow |
Mastitis |
France |
|
|
d |
100 %; 100 % |
Plasmid |
F (F29:A-:B10) |
2014 |
E. coli (ST69)/[ST69] |
Human |
Sepsis |
USA |
|
|
e |
100 %; 100 % |
Plasmid |
F (F31:A4:B1) |
2018 |
E. coli (ST410)/[ST131, ST200] |
Dog |
Cellulitis |
Portugal |
|
|
100 %; 100 % |
Plasmid |
F (F36:A1:B20) |
2008 |
E. coli (ST131) |
Human |
na |
Sweden |
||
|
100 %; 100 % |
Plasmid |
F (F2:A1:B-) |
2014 |
E. coli (na) |
Human |
Healthy |
UK |
||
|
f |
100 %; 100 % |
Plasmid |
F (F1:A6:B20) |
2007 |
E. coli (ST131)/[ST10, ST405, ST648, ST1193] |
Human |
na |
Israel |
|
|
100 %; 100 % |
Plasmid |
F (F1:A6:B20) |
2015 |
E. coli (ST131) |
Dog |
na |
Israel |
||
|
100 %; 100 % |
Plasmid |
F (F1:A6:B20) |
2015 |
E. coli (ST131) |
Human |
na |
Israel |
||
|
g |
100 %; 100 % |
Plasmid |
F (F1:A6:B20) |
2007 |
E. coli (ST131)/[ST38] |
Human |
na |
Israel |
|
|
h |
84 %; 100 % |
Plasmid |
N (A2:N5:J-) |
na |
E. coli (ST617)/[ST127] |
na |
na |
na |
|
|
i |
100 %; 100 % |
Plasmid |
F (F2:A1:B-) |
na |
E. coli (ST131)/[ST131] |
Human |
na |
USA |
|
|
100 %; 100 % |
Plasmid |
F (F2:A1:B1) |
2015 |
E. coli (ST131) |
Yak |
na |
China |
||
|
100 %; 100 % |
Plasmid |
F (F2:A1:B1) |
2015 |
E. coli (ST131) |
Yak |
na |
China |
||
|
j |
100 %; 100 % |
Plasmid |
F (F51:A-:B10) |
2010 |
E. coli (ST95)/[ST73, ST95, ST550] |
Human |
Sepsis |
Australia |
|
|
k* |
100 %; 100 % |
Plasmid |
F (F22:A1:B20) |
2009 |
E. coli (ST131)/[ST131, ST405] |
Human |
Post UTI |
Sweden |
|
|
100 %; 100% |
Contig |
– |
2013 |
E. coli (na) |
Environment |
na |
India |
||
|
100 %; 100 % |
Plasmid |
F (F73:A-:B-) |
2000 |
E. coli (ST73) |
Human |
na |
USA |
||
|
100 %; 100 % |
Plasmid |
F (F2:A-:B-) |
2008 |
E. coli (ST95) |
Human |
Sepsis |
USA |
||
|
l |
100 %; 100 % |
Plasmid |
F (F29:A-:B10) |
2014 |
E. coli (ST69)/[ST69] |
Human |
Sepsis |
USA |
|
|
m |
100 %; 100 % |
Chromosome |
– |
2015 |
E. coli (ST38)/[ST38] |
Gull |
na |
Turkey |
|
|
100 %; 100 % |
Chromosome |
– |
2014 |
E. coli (ST38) |
Mollusc |
na |
Norway |
||
|
100 %; 100 % |
Chromosome |
– |
2016 |
E. coli (ST38) |
Gull |
na |
USA |
||
|
n |
97 %; 99.97 % |
Chromosome |
– |
2015 |
E. coli (ST359)/[ST1193] |
Human |
Healthy |
Netherlands |
|
|
o |
100 %; 100 % |
Plasmid |
F (F2:A1:B-) |
2013 |
E. coli (ST131)/[ST773] |
Human |
na |
USA |
|
|
p |
100 %; 100% |
Plasmid |
F (F36:A4:B-) |
2018 |
E. coli (ST617)/[ST167] |
Dog |
na |
USA |
|
|
100 %; 100 % |
Plasmid |
F (F33:A4:B-) |
na |
E. coli (na) |
na |
na |
China |
||
|
100 %; 100 % |
Plasmid |
F (F36:A4:B-) |
2013 |
E. coli (ST617) |
Human |
na |
China |
||
|
100 %; 100 % |
Plasmid |
F (F36:A4:B-) |
na |
E. coli (ST617) |
na |
na |
na |
||
|
100 %; 100 % |
Plasmid |
F (F36:A4:B-) |
2013 |
E. coli (ST617) |
Human |
UTI |
China |
||
|
q |
100 %; 99 % |
Plasmid |
F (F48:A1-:B49) |
2009 |
E. coli (na)/[ST405] |
Human |
UTI |
Sweden |
|
|
r |
100 %; 99 % |
Plasmid |
F (F36:A-:B32) |
2007 |
E. coli (ST131)/[ST448] |
Human |
UTI |
USA |
na, Not Applicable.
*Only 100% matches from E. coli are shown.